UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:April 08,
Redhill Biopharma (NASDAQ:RDHL)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Redhill Biopharma Charts.
Redhill Biopharma (NASDAQ:RDHL)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Redhill Biopharma Charts.

Redhill Biopharma Ltd. News

RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
Wednesday 24 April 2024 (2 weeks ago) • PR Newswire (US)
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
Monday 8 April 2024 (4 weeks ago) • PR Newswire (US)
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price
Tuesday 2 April 2024 (1 month ago) • PR Newswire (US)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)
RedHill Announces New USPTO Patent Covering Talicia® Through 2034
Monday 11 March 2024 (2 months ago) • PR Newswire (US)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs
Tuesday 5 March 2024 (2 months ago) • PR Newswire (US)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)
RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication
Tuesday 20 February 2024 (2 months ago) • PR Newswire (US)
Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)
Form EFFECT - Notice of Effectiveness
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

More Redhill Biopharma Ltd. News Articles